Young Wendy B.
- SEC CIK
- 0002042847
No open-market purchases or sales filed in the past year.
Current role at each company
- ADIL Adial Pharmaceuticals, Inc.Directoras of Sep 21, 2026
- RAPP Rapport Therapeutics, Inc.Directoras of Jun 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Young Wendy B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADIL Adial Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 (view filing) | Jun 12 | 4 days | Young Wendy B.Director | PPurchase | +36.4K | $2.75 | +$100.0K | –36.4K after | Derivative |
RAPP Rapport Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Young Wendy B.Director | PPurchase | +3.50K | $22.60 | +$79.1K | +58.3%9.50K after | |
| Mar 13, 2025 (view filing) | Mar 12 | 1 day | Young Wendy B.Director | PPurchase | +6.00K | $10.21 | +$61.3K | New position6.00K after |